APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rosuvastatin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Rosuvastatin Industry Growth and Trends Forecast to 2032

26 December 2025115 pages

Choose your research edition.

Industry ResearchRosuvastatin Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Rosuvastatin Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Rosuvastatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rosuvastatin Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Rosuvastatin Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Rosuvastatin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Rosuvastatin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Rosuvastatin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rosuvastatin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Rosuvastatin include Teva Pharmaceutical Industries, Shandong Bechem Chemicals, Nanjing Frochem Tech, Lianyungang Runzhong Pharmaceutical, Jingxin Pharm, Zhejiang Hisun Pharmaceutical, Changzhou Pharmaceutical Factory, MSN Laboratories and Lunan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Rosuvastatin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Rosuvastatin market size, estimates, and forecasts are presented in terms of sales volume (W Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Rosuvastatin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Rosuvastatin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Rosuvastatin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Rosuvastatin Market by Company

Teva Pharmaceutical Industries

Shandong Bechem Chemicals

Nanjing Frochem Tech

Lianyungang Runzhong Pharmaceutical

Jingxin Pharm

Zhejiang Hisun Pharmaceutical

Changzhou Pharmaceutical Factory

MSN Laboratories

Lunan Pharmaceutical

LGM Pharma

HEC Pharm

CTX Life Sciences

Cadila Pharmaceuticals

Bal Pharma

AstraZeneca

Rosuvastatin Segment by Type

Purity 98.0%

Purity 99.0%

Other

Rosuvastatin Segment by Application

Tablet

Capsule

Others

Rosuvastatin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rosuvastatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rosuvastatin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rosuvastatin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rosuvastatin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Rosuvastatin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity 98.0% Table 2. Major Company of Purity 99.0% Table 3. Major Company of Other Table 4. Global Rosuvastatin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Rosuvastatin Sales by Type (2021-2026) & (W Tons) Table 6. Global Rosuvastatin Sales Market Share in Volume by Type (2021-2026) Table 7. Global Rosuvastatin Sales by Type (2021-2026) & (US$ Million) Table 8. Global Rosuvastatin Sales Market Share in Value by Type (2021-2026) Table 9. Global Rosuvastatin Price by Type (2021-2026) & (US$/Ton) Table 10. Global Rosuvastatin Sales by Type (2027-2032) & (W Tons) Table 11. Global Rosuvastatin Sales Market Share in Volume by Type (2027-2032) Table 12. Global Rosuvastatin Sales by Type (2027-2032) & (US$ Million) Table 13. Global Rosuvastatin Sales Market Share in Value by Type (2027-2032) Table 14. Global Rosuvastatin Price by Type (2027-2032) & (US$/Ton) Table 15. North America Rosuvastatin Sales by Type (2021-2026) & (W Tons) Table 16. North America Rosuvastatin Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Rosuvastatin Sales by Type (2021-2026) & (W Tons) Table 18. Europe Rosuvastatin Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Rosuvastatin Sales by Type (2021-2026) & (W Tons) Table 20. Asia-Pacific Rosuvastatin Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Rosuvastatin Sales by Type (2021-2026) & (W Tons) Table 22. Latin America Rosuvastatin Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Rosuvastatin Sales by Type (2021-2026) & (W Tons) Table 24. Middle East and Africa Rosuvastatin Sales by Type (2021-2026) & (US$ Million) Table 25. Rosuvastatin Industry Trends Table 26. Rosuvastatin Industry Drivers Table 27. Rosuvastatin Industry Opportunities and Challenges Table 28. Rosuvastatin Industry Restraints Table 29. Global Rosuvastatin Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Rosuvastatin Revenue Market Share by Company (2021-2026) Table 31. Global Rosuvastatin Sales by Company (2021-2026) & (W Tons) Table 32. Global Rosuvastatin Sales Share by Company (2021-2026) Table 33. Global Rosuvastatin Market Price by Company (2021-2026) & (US$/Ton) Table 34. Global Rosuvastatin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Rosuvastatin Major Company Production Sites and Headquarters Table 36. Global Rosuvastatin Company, Product Type & Application Table 37. Global Rosuvastatin Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Rosuvastatin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Rosuvastatin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Rosuvastatin Sales by Region (2021-2026) & (W Tons) Table 42. Global Rosuvastatin Sales Market Share in Volume by Region (2021-2026) Table 43. Global Rosuvastatin Sales by Region (2021-2026) & (US$ Million) Table 44. Global Rosuvastatin Sales Market Share in Value by Region (2021-2026) Table 45. Global Rosuvastatin Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Global Rosuvastatin Sales by Region (2027-2032) & (W Tons) Table 47. Global Rosuvastatin Sales Market Share in Volume by Region (2027-2032) Table 48. Global Rosuvastatin Sales by Region (2027-2032) & (US$ Million) Table 49. Global Rosuvastatin Sales Market Share in Value by Region (2027-2032) Table 50. Global Rosuvastatin Sales (W Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 51. Global Rosuvastatin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Rosuvastatin Sales by Application (2021-2026) & (W Tons) Table 53. Global Rosuvastatin Sales Market Share in Volume by Application (2021-2026) Table 54. Global Rosuvastatin Sales by Application (2021-2026) & (US$ Million) Table 55. Global Rosuvastatin Sales Market Share in Value by Application (2021-2026) Table 56. Global Rosuvastatin Price by Application (2021-2026) & (US$/Ton) Table 57. Global Rosuvastatin Sales by Application (2027-2032) & (W Tons) Table 58. Global Rosuvastatin Sales Market Share in Volume by Application (2027-2032) Table 59. Global Rosuvastatin Sales by Application (2027-2032) & (US$ Million) Table 60. Global Rosuvastatin Sales Market Share in Value by Application (2027-2032) Table 61. Global Rosuvastatin Price by Application (2027-2032) & (US$/Ton) Table 62. North America Rosuvastatin Sales by Application (2021-2026) & (W Tons) Table 63. North America Rosuvastatin Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Rosuvastatin Sales by Application (2021-2026) & (W Tons) Table 65. Europe Rosuvastatin Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Rosuvastatin Sales by Application (2021-2026) & (W Tons) Table 67. Asia-Pacific Rosuvastatin Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Rosuvastatin Sales by Application (2021-2026) & (W Tons) Table 69. Latin America Rosuvastatin Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Rosuvastatin Sales by Application (2021-2026) & (W Tons) Table 71. Middle East and Africa Rosuvastatin Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Pharmaceutical Industries Company Information Table 73. Teva Pharmaceutical Industries Business Overview Table 74. Teva Pharmaceutical Industries Rosuvastatin Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Teva Pharmaceutical Industries Rosuvastatin Product Portfolio Table 76. Teva Pharmaceutical Industries Recent Development Table 77. Shandong Bechem Chemicals Company Information Table 78. Shandong Bechem Chemicals Business Overview Table 79. Shandong Bechem Chemicals Rosuvastatin Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Shandong Bechem Chemicals Rosuvastatin Product Portfolio Table 81. Shandong Bechem Chemicals Recent Development Table 82. Nanjing Frochem Tech Company Information Table 83. Nanjing Frochem Tech Business Overview Table 84. Nanjing Frochem Tech Rosuvastatin Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Nanjing Frochem Tech Rosuvastatin Product Portfolio Table 86. Nanjing Frochem Tech Recent Development Table 87. Lianyungang Runzhong Pharmaceutical Company Information Table 88. Lianyungang Runzhong Pharmaceutical Business Overview Table 89. Lianyungang Runzhong Pharmaceutical Rosuvastatin Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Lianyungang Runzhong Pharmaceutical Rosuvastatin Product Portfolio Table 91. Lianyungang Runzhong Pharmaceutical Recent Development Table 92. Jingxin Pharm Company Information Table 93. Jingxin Pharm Business Overview Table 94. Jingxin Pharm Rosuvastatin Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Jingxin Pharm Rosuvastatin Product Portfolio Table 96. Jingxin Pharm Recent Development Table 97. Zhejiang Hisun Pharmaceutical Company Information Table 98. Zhejiang Hisun Pharmaceutical Business Overview Table 99. Zhejiang Hisun Pharmaceutical Rosuvastatin Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Zhejiang Hisun Pharmaceutical Rosuvastatin Product Portfolio Table 101. Zhejiang Hisun Pharmaceutical Recent Development Table 102. Changzhou Pharmaceutical Factory Company Information Table 103. Changzhou Pharmaceutical Factory Business Overview Table 104. Changzhou Pharmaceutical Factory Rosuvastatin Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Changzhou Pharmaceutical Factory Rosuvastatin Product Portfolio Table 106. Changzhou Pharmaceutical Factory Recent Development Table 107. MSN Laboratories Company Information Table 108. MSN Laboratories Business Overview Table 109. MSN Laboratories Rosuvastatin Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. MSN Laboratories Rosuvastatin Product Portfolio Table 111. MSN Laboratories Recent Development Table 112. Lunan Pharmaceutical Company Information Table 113. Lunan Pharmaceutical Business Overview Table 114. Lunan Pharmaceutical Rosuvastatin Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. Lunan Pharmaceutical Rosuvastatin Product Portfolio Table 116. Lunan Pharmaceutical Recent Development Table 117. LGM Pharma Company Information Table 118. LGM Pharma Business Overview Table 119. LGM Pharma Rosuvastatin Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 120. LGM Pharma Rosuvastatin Product Portfolio Table 121. LGM Pharma Recent Development Table 122. HEC Pharm Company Information Table 123. HEC Pharm Business Overview Table 124. HEC Pharm Rosuvastatin Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 125. HEC Pharm Rosuvastatin Product Portfolio Table 126. HEC Pharm Recent Development Table 127. CTX Life Sciences Company Information Table 128. CTX Life Sciences Business Overview Table 129. CTX Life Sciences Rosuvastatin Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 130. CTX Life Sciences Rosuvastatin Product Portfolio Table 131. CTX Life Sciences Recent Development Table 132. Cadila Pharmaceuticals Company Information Table 133. Cadila Pharmaceuticals Business Overview Table 134. Cadila Pharmaceuticals Rosuvastatin Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 135. Cadila Pharmaceuticals Rosuvastatin Product Portfolio Table 136. Cadila Pharmaceuticals Recent Development Table 137. Bal Pharma Company Information Table 138. Bal Pharma Business Overview Table 139. Bal Pharma Rosuvastatin Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 140. Bal Pharma Rosuvastatin Product Portfolio Table 141. Bal Pharma Recent Development Table 142. AstraZeneca Company Information Table 143. AstraZeneca Business Overview Table 144. AstraZeneca Rosuvastatin Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 145. AstraZeneca Rosuvastatin Product Portfolio Table 146. AstraZeneca Recent Development Table 147. North America Rosuvastatin Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 148. North America Rosuvastatin Sales by Country (2021-2026) & (W Tons) Table 149. North America Rosuvastatin Sales Market Share by Country (2021-2026) Table 150. North America Rosuvastatin Sales Forecast by Country (2027-2032) & (W Tons) Table 151. North America Rosuvastatin Sales Market Share Forecast by Country (2027-2032) Table 152. North America Rosuvastatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. North America Rosuvastatin Market Size by Country (2021-2026) & (US$ Million) Table 154. North America Rosuvastatin Market Share by Country (2021-2026) Table 155. North America Rosuvastatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. North America Rosuvastatin Market Share Forecast by Country (2027-2032) Table 157. Europe Rosuvastatin Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 158. Europe Rosuvastatin Sales by Country (2021-2026) & (W Tons) Table 159. Europe Rosuvastatin Sales Market Share by Country (2021-2026) Table 160. Europe Rosuvastatin Sales Forecast by Country (2027-2032) & (W Tons) Table 161. Europe Rosuvastatin Sales Market Share Forecast by Country (2027-2032) Table 162. Europe Rosuvastatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Europe Rosuvastatin Market Size by Country (2021-2026) & (US$ Million) Table 164. Europe Rosuvastatin Market Share by Country (2021-2026) Table 165. Europe Rosuvastatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Europe Rosuvastatin Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Rosuvastatin Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Rosuvastatin Sales by Country (2021-2026) & (W Tons) Table 169. Asia-Pacific Rosuvastatin Sales Market Share by Country (2021-2026) Table 170. Asia-Pacific Rosuvastatin Sales Forecast by Country (2027-2032) & (W Tons) Table 171. Asia-Pacific Rosuvastatin Sales Market Share Forecast by Country (2027-2032) Table 172. Asia-Pacific Rosuvastatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Asia-Pacific Rosuvastatin Market Size by Country (2021-2026) & (US$ Million) Table 174. Asia-Pacific Rosuvastatin Market Share by Country (2021-2026) Table 175. Asia-Pacific Rosuvastatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Asia-Pacific Rosuvastatin Market Share Forecast by Country (2027-2032) Table 177. Latin America Rosuvastatin Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 178. Latin America Rosuvastatin Sales by Country (2021-2026) & (W Tons) Table 179. Latin America Rosuvastatin Sales Market Share by Country (2021-2026) Table 180. Latin America Rosuvastatin Sales Forecast by Country (2027-2032) & (W Tons) Table 181. Latin America Rosuvastatin Sales Market Share Forecast by Country (2027-2032) Table 182. Latin America Rosuvastatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Latin America Rosuvastatin Market Size by Country (2021-2026) & (US$ Million) Table 184. Latin America Rosuvastatin Market Share by Country (2021-2026) Table 185. Latin America Rosuvastatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Latin America Rosuvastatin Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Rosuvastatin Market Size Growth Rate (CAGR) by Country (W Tons): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Rosuvastatin Sales by Country (2021-2026) & (W Tons) Table 189. Middle East and Africa Rosuvastatin Sales Market Share by Country (2021-2026) Table 190. Middle East and Africa Rosuvastatin Sales Forecast by Country (2027-2032) & (W Tons) Table 191. Middle East and Africa Rosuvastatin Sales Market Share Forecast by Country (2027-2032) Table 192. Middle East and Africa Rosuvastatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Middle East and Africa Rosuvastatin Market Size by Country (2021-2026) & (US$ Million) Table 194. Middle East and Africa Rosuvastatin Market Share by Country (2021-2026) Table 195. Middle East and Africa Rosuvastatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Middle East and Africa Rosuvastatin Market Share Forecast by Country (2027-2032) Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. Rosuvastatin Distributors List Table 200. Rosuvastatin Customers List Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. Rosuvastatin Image Figure 2. Global Rosuvastatin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rosuvastatin Market Size (2021-2032) & (US$ Million) Figure 4. Global Rosuvastatin Sales (2021-2032) & (W Tons) Figure 5. Purity 98.0% Image Figure 6. Global Purity 98.0% Sales YoY Growth (2021-2032) & (W Tons) Figure 7. Purity 99.0% Image Figure 8. Global Purity 99.0% Sales YoY Growth (2021-2032) & (W Tons) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (W Tons) Figure 11. Global Rosuvastatin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Rosuvastatin Market Share by Type 2025 VS 2032 Figure 13. North America Rosuvastatin Sales Market Share in Volume by Type in 2025 Figure 14. North America Rosuvastatin Sales Market Share in Value by Type in 2025 Figure 15. Europe Rosuvastatin Sales Market Share in Volume by Type in 2025 Figure 16. Europe Rosuvastatin Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Rosuvastatin Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Rosuvastatin Sales Market Share in Value by Type in 2025 Figure 19. Latin America Rosuvastatin Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Rosuvastatin Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Rosuvastatin Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Rosuvastatin Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Rosuvastatin Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Tablet Image Figure 26. Global Tablet Sales YoY Growth (2021-2032) & (W Tons) Figure 27. Capsule Image Figure 28. Global Capsule Sales YoY Growth (2021-2032) & (W Tons) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (W Tons) Figure 31. Global Rosuvastatin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Rosuvastatin Market Share by Application 2025 VS 2032 Figure 33. North America Rosuvastatin Sales Market Share in Volume by Application in 2025 Figure 34. North America Rosuvastatin Sales Market Share in Value by Application in 2025 Figure 35. Europe Rosuvastatin Sales Market Share in Volume by Application in 2025 Figure 36. Europe Rosuvastatin Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Rosuvastatin Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Rosuvastatin Sales Market Share in Value by Application in 2025 Figure 39. Latin America Rosuvastatin Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Rosuvastatin Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Rosuvastatin Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Rosuvastatin Sales Market Share in Value by Application in 2025 Figure 43. North America Rosuvastatin Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 44. North America Rosuvastatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Rosuvastatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Rosuvastatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Rosuvastatin Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 48. Europe Rosuvastatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Rosuvastatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Rosuvastatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Rosuvastatin Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 52. Asia-Pacific Rosuvastatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Rosuvastatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Rosuvastatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Rosuvastatin Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 56. Latin America Rosuvastatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Rosuvastatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Rosuvastatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Rosuvastatin Sales by Country: 2021 VS 2025 VS 2032 (W Tons) Figure 60. Middle East and Africa Rosuvastatin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Rosuvastatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Rosuvastatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Rosuvastatin Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Rosuvastatin Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Purity 98.0%
  • Purity 99.0%
  • Other
Applications
  • Tablet
  • Capsule
  • Others
Companies covered
  • Teva Pharmaceutical Industries
  • Shandong Bechem Chemicals
  • Nanjing Frochem Tech
  • Lianyungang Runzhong Pharmaceutical
  • Jingxin Pharm
  • Zhejiang Hisun Pharmaceutical
  • Changzhou Pharmaceutical Factory
  • MSN Laboratories
  • Lunan Pharmaceutical
  • LGM Pharma
  • HEC Pharm
  • CTX Life Sciences
  • Cadila Pharmaceuticals
  • Bal Pharma
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rosuvastatin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Rosuvastatin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Rosuvastatin Market by Type
  6. 1.3.1 Purity 98.0%
  7. 1.3.2 Purity 99.0%
  8. 1.3.3 Other
  9. 1.4 Global Rosuvastatin Market Size by Type
  10. 1.4.1 Global Rosuvastatin Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Rosuvastatin Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Rosuvastatin Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Rosuvastatin Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Rosuvastatin Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Rosuvastatin Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Rosuvastatin Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Rosuvastatin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Rosuvastatin Industry Trends
  2. 2.2 Rosuvastatin Industry Drivers
  3. 2.3 Rosuvastatin Industry Opportunities and Challenges
  4. 2.4 Rosuvastatin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Rosuvastatin Revenue (2021-2026)
  2. 3.2 Global Top Players by Rosuvastatin Sales (2021-2026)
  3. 3.3 Global Top Players by Rosuvastatin Price (2021-2026)
  4. 3.4 Global Rosuvastatin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rosuvastatin Major Company Production Sites & Headquarters
  6. 3.6 Global Rosuvastatin Company, Product Type & Application
  7. 3.7 Global Rosuvastatin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rosuvastatin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rosuvastatin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rosuvastatin Tier 1, Tier 2, and Tier 3
4 Rosuvastatin Regional Status and Outlook
  1. 4.1 Global Rosuvastatin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Rosuvastatin Historic Market Size by Region
  3. 4.2.1 Global Rosuvastatin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Rosuvastatin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Rosuvastatin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Rosuvastatin Forecasted Market Size by Region
  7. 4.3.1 Global Rosuvastatin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Rosuvastatin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Rosuvastatin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Rosuvastatin by Application
  1. 5.1 Rosuvastatin Market by Application
  2. 5.1.1 Tablet
  3. 5.1.2 Capsule
  4. 5.1.3 Others
  5. 5.2 Global Rosuvastatin Market Size by Application
  6. 5.2.1 Global Rosuvastatin Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Rosuvastatin Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Rosuvastatin Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Rosuvastatin Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Rosuvastatin Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Rosuvastatin Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Rosuvastatin Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Rosuvastatin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries
  2. 6.1.1 Teva Pharmaceutical Industries Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Rosuvastatin Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 6.2 Shandong Bechem Chemicals
  8. 6.2.1 Shandong Bechem Chemicals Company Information
  9. 6.2.2 Shandong Bechem Chemicals Business Overview
  10. 6.2.3 Shandong Bechem Chemicals Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shandong Bechem Chemicals Rosuvastatin Product Portfolio
  12. 6.2.5 Shandong Bechem Chemicals Recent Developments
  13. 6.3 Nanjing Frochem Tech
  14. 6.3.1 Nanjing Frochem Tech Company Information
  15. 6.3.2 Nanjing Frochem Tech Business Overview
  16. 6.3.3 Nanjing Frochem Tech Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Nanjing Frochem Tech Rosuvastatin Product Portfolio
  18. 6.3.5 Nanjing Frochem Tech Recent Developments
  19. 6.4 Lianyungang Runzhong Pharmaceutical
  20. 6.4.1 Lianyungang Runzhong Pharmaceutical Company Information
  21. 6.4.2 Lianyungang Runzhong Pharmaceutical Business Overview
  22. 6.4.3 Lianyungang Runzhong Pharmaceutical Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Lianyungang Runzhong Pharmaceutical Rosuvastatin Product Portfolio
  24. 6.4.5 Lianyungang Runzhong Pharmaceutical Recent Developments
  25. 6.5 Jingxin Pharm
  26. 6.5.1 Jingxin Pharm Company Information
  27. 6.5.2 Jingxin Pharm Business Overview
  28. 6.5.3 Jingxin Pharm Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Jingxin Pharm Rosuvastatin Product Portfolio
  30. 6.5.5 Jingxin Pharm Recent Developments
  31. 6.6 Zhejiang Hisun Pharmaceutical
  32. 6.6.1 Zhejiang Hisun Pharmaceutical Company Information
  33. 6.6.2 Zhejiang Hisun Pharmaceutical Business Overview
  34. 6.6.3 Zhejiang Hisun Pharmaceutical Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Zhejiang Hisun Pharmaceutical Rosuvastatin Product Portfolio
  36. 6.6.5 Zhejiang Hisun Pharmaceutical Recent Developments
  37. 6.7 Changzhou Pharmaceutical Factory
  38. 6.7.1 Changzhou Pharmaceutical Factory Company Information
  39. 6.7.2 Changzhou Pharmaceutical Factory Business Overview
  40. 6.7.3 Changzhou Pharmaceutical Factory Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Changzhou Pharmaceutical Factory Rosuvastatin Product Portfolio
  42. 6.7.5 Changzhou Pharmaceutical Factory Recent Developments
  43. 6.8 MSN Laboratories
  44. 6.8.1 MSN Laboratories Company Information
  45. 6.8.2 MSN Laboratories Business Overview
  46. 6.8.3 MSN Laboratories Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 MSN Laboratories Rosuvastatin Product Portfolio
  48. 6.8.5 MSN Laboratories Recent Developments
  49. 6.9 Lunan Pharmaceutical
  50. 6.9.1 Lunan Pharmaceutical Company Information
  51. 6.9.2 Lunan Pharmaceutical Business Overview
  52. 6.9.3 Lunan Pharmaceutical Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Lunan Pharmaceutical Rosuvastatin Product Portfolio
  54. 6.9.5 Lunan Pharmaceutical Recent Developments
  55. 6.10 LGM Pharma
  56. 6.10.1 LGM Pharma Company Information
  57. 6.10.2 LGM Pharma Business Overview
  58. 6.10.3 LGM Pharma Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 LGM Pharma Rosuvastatin Product Portfolio
  60. 6.10.5 LGM Pharma Recent Developments
  61. 6.11 HEC Pharm
  62. 6.11.1 HEC Pharm Company Information
  63. 6.11.2 HEC Pharm Business Overview
  64. 6.11.3 HEC Pharm Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 HEC Pharm Rosuvastatin Product Portfolio
  66. 6.11.5 HEC Pharm Recent Developments
  67. 6.12 CTX Life Sciences
  68. 6.12.1 CTX Life Sciences Company Information
  69. 6.12.2 CTX Life Sciences Business Overview
  70. 6.12.3 CTX Life Sciences Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 CTX Life Sciences Rosuvastatin Product Portfolio
  72. 6.12.5 CTX Life Sciences Recent Developments
  73. 6.13 Cadila Pharmaceuticals
  74. 6.13.1 Cadila Pharmaceuticals Company Information
  75. 6.13.2 Cadila Pharmaceuticals Business Overview
  76. 6.13.3 Cadila Pharmaceuticals Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Cadila Pharmaceuticals Rosuvastatin Product Portfolio
  78. 6.13.5 Cadila Pharmaceuticals Recent Developments
  79. 6.14 Bal Pharma
  80. 6.14.1 Bal Pharma Company Information
  81. 6.14.2 Bal Pharma Business Overview
  82. 6.14.3 Bal Pharma Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bal Pharma Rosuvastatin Product Portfolio
  84. 6.14.5 Bal Pharma Recent Developments
  85. 6.15 AstraZeneca
  86. 6.15.1 AstraZeneca Company Information
  87. 6.15.2 AstraZeneca Business Overview
  88. 6.15.3 AstraZeneca Rosuvastatin Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 AstraZeneca Rosuvastatin Product Portfolio
  90. 6.15.5 AstraZeneca Recent Developments
7 North America by Country
  1. 7.1 North America Rosuvastatin Sales by Country
  2. 7.1.1 North America Rosuvastatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Rosuvastatin Sales by Country (2021-2026)
  4. 7.1.3 North America Rosuvastatin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Rosuvastatin Market Size by Country
  6. 7.2.1 North America Rosuvastatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Rosuvastatin Market Size by Country (2021-2026)
  8. 7.2.3 North America Rosuvastatin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Rosuvastatin Sales by Country
  2. 8.1.1 Europe Rosuvastatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Rosuvastatin Sales by Country (2021-2026)
  4. 8.1.3 Europe Rosuvastatin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Rosuvastatin Market Size by Country
  6. 8.2.1 Europe Rosuvastatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Rosuvastatin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Rosuvastatin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Rosuvastatin Sales by Country
  2. 9.1.1 Asia-Pacific Rosuvastatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Rosuvastatin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Rosuvastatin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Rosuvastatin Market Size by Country
  6. 9.2.1 Asia-Pacific Rosuvastatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Rosuvastatin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Rosuvastatin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Rosuvastatin Sales by Country
  2. 10.1.1 South America Rosuvastatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Rosuvastatin Sales by Country (2021-2026)
  4. 10.1.3 South America Rosuvastatin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Rosuvastatin Market Size by Country
  6. 10.2.1 South America Rosuvastatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Rosuvastatin Market Size by Country (2021-2026)
  8. 10.2.3 South America Rosuvastatin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Rosuvastatin Sales by Country
  2. 11.1.1 Middle East and Africa Rosuvastatin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Rosuvastatin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Rosuvastatin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Rosuvastatin Market Size by Country
  6. 11.2.1 Middle East and Africa Rosuvastatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Rosuvastatin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Rosuvastatin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Rosuvastatin Value Chain Analysis
  2. 12.1.1 Rosuvastatin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Rosuvastatin Production Mode & Process
  7. 12.2 Rosuvastatin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Rosuvastatin Distributors
  10. 12.2.3 Rosuvastatin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst